SCHEMBL29673152

SCHEMBL29673152

Cc1ccc(CCCCO)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRB2 P47870 1/20 0.37
BCHE P06276 1/20 0.36
ACLY P53396 3/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HPGD P15428 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRL1 P41146 1/20 0.33
PPARG P37231 1/20 0.33
TLR8 Q9NR97 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24543287 1.00 GABRA1 (0.37) GABRA1GABRG2GABRB3GABRB2BCHE
SCHEMBL13114188 0.94 GABRA1 (0.38) GABRA1GABRG2GABRB3GABRB2RAB9A
SCHEMBL18448344 0.86 GABRA1 (0.36) GABRA1GABRG2GABRB3GABRB2RAB9A
SCHEMBL2355598 0.82 TAAR1 (0.40) GABRA1GABRG2GABRB3GABRB2RAB9A
SCHEMBL17586140 0.81 TYR (0.47) RAB9ANPC1MAPTATML3MBTL1
SCHEMBL1802629 0.81 ACLY (0.50) ACLY
SCHEMBL14573964 0.81 TP53 (0.40) BCHERAB9ANPC1MAPT
SCHEMBL25407039 0.81 MAPT (0.39) RAB9ANPC1MAPTATML3MBTL1
SCHEMBL19254235 0.81 CTRC (0.44) RAB9ANPC1MAPTATML3MBTL1
SCHEMBL9152124 0.79 ACLY (0.52) ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022127827-A1 KRASG12C PROTEIN MUTATION INHIBITOR AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 上海维申医药有限公司 2022-06-23 WO disclosed
CN-114644631-A KRAS G12C protein mutation inhibitor, preparation method thereof, pharmaceutical composition and application thereof 上海维申医药有限公司 2022-06-21 CN disclosed